Zobrazeno 1 - 10
of 179
pro vyhledávání: '"W M, Wiersinga"'
Autor:
P. Perros, L. Hegedüs, L. Bartalena, C. Marcocci, G. J. Kahaly, L. Baldeschi, M. Salvi, J. H. Lazarus, A. Eckstein, S. Pitz, K. Boboridis, P. Anagnostis, G. Ayvaz, A. Boschi, T. H. Brix, N. Currò, O. Konuk, M. Marinò, A. L. Mitchell, B. Stankovic, F. B. Törüner, G. von Arx, M. Zarković, W. M. Wiersinga
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-6 (2017)
Abstract Background Graves’ orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status. Current evidence suggests that the incidence of GO in Europe may
Externí odkaz:
https://doaj.org/article/411a63ef25e042908de19019e062161d
Autor:
L Bartalena, G J Kahaly, L Baldeschi, C M Dayan, A Eckstein, C Marcocci, M Marinò, B Vaidya, W M Wiersinga, Goksun Ayvaz, Onur Konuk, Jasmina Ciric, Bijliana Beleslin, Antonella Boschi, Maria Cristina Burlacu, Dan Morris, Rosario Le Moli, Antonio Marino, Justin McKee, Nicola Zammit, Dagmar Führer, Ioana Pereni, Michael Schittkowski, Dirk Raddatz, Vickie Lee, Karim Meeran, Juliette Abeillon, Thia Soui Thcong, Katharina Ponto, Ilaria Muller, Nicola Currò, Christoph Hintschich, Roland Gärtner, Simon Pearce, Lucy Clarke, Thomas Brix, Dorte Bechtold, Gottfried Rudovfsky, Nicole Fichter, Laurence Du Pasquier, Julia Meney, Francesca Menconi, Giulia Lanzolla, Gangadhara Sundar, Samantha Peiling Yung, Kostas Boboridis, Panagiotis Anagnostis, Marta Pérez Lopez, Carlos Javier Sanchez, Maria Laura Tanda, Simone Donati, Andrea Papp, Shuren Li, Anna Jablonska, Piotr Miskiewicz, Jelena Juri Mandic, Maja Baretic
Publikováno v:
European journal of endocrinology, Vol. 185, no. 4, p. G43-G67 (2021)
European Journal of Endocrinology, 185(4), G43-G67. BioScientifica Ltd.
European Journal of Endocrinology, 185(4), G43-G67. BioScientifica Ltd.
Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Choice of treatment should be based on the assessment of clinical activity and severity of GO. Early referral to specialized centers is fundamental for mos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71629229c4ad08577973ef207b8d40a5
https://doi.org/10.1530/eje-21-0479
https://doi.org/10.1530/eje-21-0479
Autor:
Onyebuchi E. Okosieme, Danila Covelli, Jürg Lareida, Nicola Currò, Nicole Fichter, Daniel J. Morris, Thomas Heiberg Brix, Miloš Žarković, Simone Donati, Maria-Christina Burlacu, Biljana Beleslin, W. M. Wiersinga, Eugogo, Chantal Daumerie, Petros Perros, Fusun Balos Toruner, Luigi Bartalena, Onur Konuk, Jasmina Ciric, Susanne Pitz, Göksun Ayvaz, Mario Salvi, George J. Kahaly, Laszlo Hegedüs
Publikováno v:
Journal of endocrinological investigation, Vol. 44, no.2, p. 371-378 (2021)
Žarković, M, Wiersinga, W, Perros, P, Bartalena, L, Donati, S, Okosieme, O, Morris, D, Fichter, N, Lareida, J, Daumerie, C, Burlacu, M C, Kahaly, G J, Pitz, S, Beleslin, B, Ćirić, J, Ayvaz, G, Konuk, O, Törüner, F B, Salvi, M, Covelli, D, Curro, N, Hegedüs, L, Brix, T & EUGOGO (European Group on Graves’ Orbitopathy) 2021, ' Antithyroid drugs in Graves’ hyperthyroidism : differences between “block and replace” and “titration” regimes in frequency of euthyroidism and Graves’ orbitopathy during treatment ', Journal of Endocrinological Investigation, vol. 44, no. 2, pp. 371-378 . https://doi.org/10.1007/s40618-020-01320-7
Žarković, M, Wiersinga, W, Perros, P, Bartalena, L, Donati, S, Okosieme, O, Morris, D, Fichter, N, Lareida, J, Daumerie, C, Burlacu, M C, Kahaly, G J, Pitz, S, Beleslin, B, Ćirić, J, Ayvaz, G, Konuk, O, Törüner, F B, Salvi, M, Covelli, D, Curro, N, Hegedüs, L, Brix, T & EUGOGO (European Group on Graves’ Orbitopathy) 2021, ' Antithyroid drugs in Graves’ hyperthyroidism : differences between “block and replace” and “titration” regimes in frequency of euthyroidism and Graves’ orbitopathy during treatment ', Journal of Endocrinological Investigation, vol. 44, no. 2, pp. 371-378 . https://doi.org/10.1007/s40618-020-01320-7
Purpose: Whereas antithyroid drugs (ATD) are the preferred treatment modality for Graves’ hyperthyroidism (GH), there is still controversy about the optimal regimen for delivering ATD. To evaluate whether ‘Block and Replace’ (B + R) and ‘Titr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f56e4e88897ac16d75544aba691bb0bc
https://hdl.handle.net/2078.1/261087
https://hdl.handle.net/2078.1/261087
Autor:
E. Masiello, Silvia Ippolito, S Rosetti, Daniela Gallo, Maria Laura Tanda, E. Bianconi, C Cusini, Luca Chiovato, Giovanni Veronesi, W. M. Wiersinga, Luigi Bartalena, Eliana Piantanida, Jessica Sabatino, P Premoli
Publikováno v:
Journal of endocrinological investigation, 41(12), 1425-1432. Editrice Kurtis s.r.l.
Background: Antithyroid drugs (ATDs) are first-line treatment for Graves’ hyperthyroidism worldwide, but relapses are frequent. The reliability of individual risk factors to predict at baseline subsequent relapse is poor. Predictive scores grouping
Autor:
G. E. Krassas, George J. Kahaly, Michele Marinò, L Baldeschi, Giovanni Veronesi, Antonella Boschi, Claudio Marcocci, Petros Perros, M Stahl, Claudio Azzolini, Marco Nardi, M. R. Soeters, Nicola Currò, M. P. Mourits, Kostas G. Boboridis, Chantal Daumerie, L. Sassi, G von Arx, W. M. Wiersinga, M Bernard, Luigi Bartalena, Mario Salvi, C Bournaud
Publikováno v:
Journal of endocrinological investigation, 40(5), 547-553. Editrice Kurtis s.r.l.
Intravenous glucocorticoids (ivGCs) given as 12-weekly infusions are the first-line treatment for moderate-to-severe and active Graves’ orbitopathy (GO), but they are not always effective. In this study, we evaluated whether response at 6 weeks cor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bde5cc5c60fc36ba6a599219d4a1f90b
https://pure.amc.nl/en/publications/does-early-response-to-intravenous-glucocorticoids-predict-the-final-outcome-in-patients-with-moderatetosevere-and-active-graves-orbitopathy(03971e8f-5400-4a24-8272-ed4e0894339e).html
https://pure.amc.nl/en/publications/does-early-response-to-intravenous-glucocorticoids-predict-the-final-outcome-in-patients-with-moderatetosevere-and-active-graves-orbitopathy(03971e8f-5400-4a24-8272-ed4e0894339e).html
Autor:
B. C. J. M. Fauser, E. R. de Kloet, J. S. E. Laven, P. Lips, R. P. J. Michels, A. M. Pereira, J. M. A. Sitsen, W. M. Wiersinga
Publikováno v:
Farmacologie ISBN: 9789036815994
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d9286ce1ec81e47ed94c7dd734a9814
https://doi.org/10.1007/978-90-368-1600-7_4
https://doi.org/10.1007/978-90-368-1600-7_4
Publikováno v:
Clinical endocrinology, 87(6), 838-843. Wiley-Blackwell
Clinical Endocrinology, 87(6), 838-843. Wiley-Blackwell
Clinical Endocrinology, 87(6). Wiley-Blackwell
Clinical Endocrinology, 87(6), 838-843. Wiley-Blackwell
Clinical Endocrinology, 87(6). Wiley-Blackwell
ObjectiveTo evaluate whether women during early pregnancy with “hypothyroidism” symptoms are at risk of biochemically defined hypothyroidism. The 2017 Guidelines of the American Thyroid Association (ATA) recommend case-finding on the basis of sym
Publikováno v:
Journal of Endocrinological Investigation
Journal of endocrinological investigation, 21(5), 329-333. Editrice Kurtis s.r.l.
Journal of endocrinological investigation, 21(5), 329-333. Editrice Kurtis s.r.l.
The case history of a 56-year-old man is described who suffered from severe adrenocorticotrophic hormone (ACTH)-dependent Cushing’s syndrome. The clinical course was complicated by simultaneous infections with Pneumocystis carinii, Staphylococcus a
Publikováno v:
Journal of Neuroendocrinology. 23:310-319
The biological function of thyrostimulin, consisting of the GPA2 and GPB5 subunit, is currently poorly understood. The recent observation that pro-inflammatory cytokines up-regulate the transcription of GPB5 in vitro suggested a role for thyrostimuli
Autor:
W. M. Wiersinga, Antonella Lupetti, Y Vardizer, A C Lankester, S Vandelanotte, Lelio Baldeschi
Publikováno v:
European journal of endocrinology / European Federation of Endocrine Societies, 161(2), 369-373. BioScientifica Ltd.
ObjectiveFor many years, the treatment of X-linked childhood cerebral adrenoleukodystrophy (XALD) consisted of hydrocortisone replacement and a mixture of short chain-fatty acids, known as ‘Lorenzo's oil’. Recently, bone marrow transplantation (B